Bioprocess Containers Market Report 2025

This Bioprocess Containers market report covers market characteristics, size & growth, segmentation, regional & country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The bioprocess containers market size has grown exponentially in recent years. It will grow from $5.13 billion in 2024 to $6.43 billion in 2025 at a compound annual growth rate (CAGR) of 25.4%. The growth in the historic period can be attributed to growth in biopharmaceutical industry, government investments in research and development, increase in privatization of laboratory services, rise in healthcare spending.

The bioprocess containers market size is expected to see exponential growth in the next few years. It will grow to $17.56 billion in 2029 at a compound annual growth rate (CAGR) of 28.5%. The growth in the forecast period can be attributed to rising healthcare investments, emerging markets expansion, regulatory support, rise in disposable income. Major trends in the forecast period include sustainability and eco-friendly solutions, digitalization and data analytics, outsourcing and contract manufacturing, customization and modular systems, personalized medicine and patient-centric manufacturing.

The expansion of biopharmaceutical research and development (R&D) activities is a primary driver for the growth of the bioprocess containers market. The evolution of traditional drug development methods in biopharmaceutical R&D aims to expedite the delivery of medicines to patients, reduce operational costs, and enhance decision-making through the integration of data, digital technologies, and artificial intelligence (AI). According to an institutional report by IQVIA in February 2022, the global biopharmaceutical industry is witnessing robust growth, with over 6,000 products in active development. As the biopharmaceutical landscape continues to flourish, there is a concurrent surge in the demand for bioprocess containers to ensure the safe and uncontaminated handling and transportation of these critical products. This underscores the integral role of bioprocess containers in supporting the momentum of biopharmaceutical R&D.

Anticipated growth in the demand for biologics and biosimilars is poised to drive the bioprocess containers market. These innovative medications, used for various medical conditions, are witnessing increased adoption. Bioprocess containers, particularly those tailored for single-use applications, present notable advantages in terms of flexibility, scalability, cost-effectiveness, and reduced contamination risks. The Pharmaceutical Research and Manufacturers of America (PHRMA) reported in 2022 that 40 biosimilars have received approval, with 27 currently available in the United States. As the competition between biosimilars and biologic brands intensifies, the need for efficient and secure bioprocess containers grows. This trend is expected to shape the trajectory of the bioprocess container market in response to the expanding demand and usage of biologics and biosimilars.

Technological advancement is a significant trend gaining traction in the bioprocess container market. Major companies in this sector are concentrating on delivering technologically sophisticated products to address the rapidly evolving demands of the industry and bolster their market positions. These firms are incorporating next-generation technologies into their offerings, including depth filtration, disposable chromatography, sterile filtration, ultrafiltration (UF)/defiltration (DF), virus filtration, and others. These advanced products provide improved sample protection, enhanced productivity, and additional advantages. For example, in October 2022, Single Use Support GmbH, a biopharmaceutical solutions company based in Austria, introduced the IRIS single-use bag line, designed for the secure storage, transport, and cryopreservation of drug substances. Serving the biopharmaceutical industry, these bags function as bioprocess containers for the storage, transport, and cryopreservation of drug substances, particularly biologics and cell & gene therapies. They can be customized to fulfill manufacturers' specific needs, such as volume, number of ports, and attached tubing. These bags are engineered to maintain high integrity at extremely low temperatures, reaching as low as -150°C (-238°F), thus ensuring the safety and sterility of their contents during handling.

Leading companies in the bioprocess container market are actively engaged in the development of innovative products, such as flexible single-use systems, to cater to a broader customer base, drive increased sales, and boost overall revenue. Flexible single-use systems, also known as single-use technologies (SUT) or disposable systems, play a crucial role in bioprocessing equipment designed for one-time use in the production and processing of biopharmaceuticals, encompassing biologics and vaccines. An exemplar of this trend is Single Use Support, an Austrian-based provider of process solutions in biopharmaceutical fluid management, which introduced the IRIS Single-Use Bag Line bioprocess container in October 2022. This solution offers flexibility and customization for bioprocessing and cryopreservation of biologics, cell and gene therapies, with attributes such as minimal extractables and leachables, ensuring the highest integrity even at temperatures as low as -150°C (-238°F). Its reliability and safety make it a preferred option for the transportation and storage of liquids.

In May 2024, Novo Holdings, an investment company based in Denmark, acquired Single Use Support for an undisclosed sum. This acquisition aims to enhance Novo Holdings' life sciences services and manufacturing capabilities, enabling them to better assist pharmaceutical companies in managing biologics and advanced therapies. Single Use Support is a life sciences tools company located in Austria, specializing in fluid management services designed for the pharmaceutical industry, with a focus on the fluid and cold-chain management of pharmaceutical substances.

Major companies operating in the bioprocess containers market include Sartorius Stedim Biotech S.A., Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Sartorius AG, Compagnie de Saint-Gobain S.A., Lonza Group AG, Avantor Inc., Eppendorf AG, Meissner Filtration Products Inc., Corning Incorporated, GE Healthcare Technologies Inc., Fluids Control Inc., Neta Scientific Incorporated, ALLpaQ Packaging Group plc, Kawasumi Laboratories Inc., F.L. Medical SRL, Sani-Tech West Inc., Cellon SA, Celltainer Biotech BV, Entegris Inc., Flexboy AG, GE Healthcare Life Sciences, GEA Group AG, GEMÜ Group, GVS Group Ltd., Integra Companies, Kuhner AG, L.B. Bohle Maschinen + Verfahren GmbH.

Bioprocess containers are single-use containers utilized for critical sterile liquid-handling applications in the biopharmaceutical industry. They are employed for liquid cell culture media, reagents, buffers, containment, and storage vessels for intermediate and final products generated from manufacturing processes.

The main types of bioprocess containers include 2D bioprocess containers, 3D bioprocess containers, tank liners, and other containers and accessories. The 2D bioprocess container refers to containers with a two-dimensional design for sterile liquid handling. They are designed for small, simple BPCs ranging from 50 ML to 50 L. These containers are created from two sheets of film, heat-sealed around the perimeter to form a pillow-shaped chamber. Bioprocess containers find applications in biopharmaceutical companies, life science R&D companies, and others for upstream and downstream processes, as well as product development applications.

The bioprocess containers market research report is one of a series of new reports that provides bioprocess containers market statistics, including bioprocess containers industry global market size, regional shares, competitors with a bioprocess containers market share, detailed bioprocess containers market segments, market trends and opportunities, and any further data you may need to thrive in the bioprocess containers industry. This bioprocess containers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

North America was the largest region in the bioprocess containers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioprocess containers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the bioprocess containers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.

The bioprocess containers market consists of sales of Standard BioProcess Containers, Bioprocessing Films, Fluid Transfer Solutions, and Retention Devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.